SCHEMBL2906901

SCHEMBL2906901

O=C(NC1CCCCC1)C(C1CCCCC1)C1(C(O)c2cccc(Cl)c2Cl)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.40
RAB9A P51151 7/20 0.39
NPC1 O15118 6/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
TSHR P16473 1/20 0.37
MAPK14 Q16539 1/20 0.37
CYP3A4 P08684 2/20 0.36
KCNH2 Q12809 2/20 0.36
NR1H4 Q96RI1 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
ATM Q13315 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
NR3C1 P04150 1/20 0.35
PGR P06401 1/20 0.35
NR3C2 P08235 1/20 0.35
PYGL P06737 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907592 0.84 NPC1 (0.42) CNR1RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL2915021 0.82 KCNH2 (0.44) RAB9ANPC1SMN1; SMN2TSHRCYP3A4
SCHEMBL2913040 0.82 TSHR (0.44) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL2912425 0.82 TSHR (0.40) CNR1RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL3651303 0.79 CYP3A4 (0.38) CNR1RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL4038088 0.78 RAB9A (0.44) CNR1RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL4038304 0.78 RAB9A (0.44) CNR1RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL2915028 0.78 KMT2A (0.43) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL2909615 0.77 C3AR1 (0.43) SMN1; SMN2TSHRCYP3A4CYP2D6CYP2C9
SCHEMBL2913162 0.77 KMT2A (0.42) RAB9ANPC1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed